Sarah Knerr1, Karen J Wernli2, Kathleen Leppig3, Kelly Ehrlich2, Amanda L Graham4, David Farrell5, Chalanda Evans6, George Luta7, Marc D Schwartz6, Suzanne C O'Neill6. 1. Group Health Research Institute, Seattle, WA 98101, USA(1). Electronic address: saknerr@uw.edu. 2. Group Health Research Institute, Seattle, WA 98101, USA(1). 3. Clinical Genetics, Group Health Cooperative, Seattle, WA 98112, USA(1). 4. Schroeder Institute for Tobacco Research and Policy Studies, Truth Initiative, Washington, DC 20001, USA. 5. People Designs, Durham, NC 27705, USA. 6. Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA. 7. Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA; Department of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC 20007, USA.
Abstract
BACKGROUND: Mammographic breast density is one of the strongest risk factors for breast cancer after age and family history. Mandatory breast density disclosure policies are increasing nationally without clear guidance on how to communicate density status to women. Coupling density disclosure with personalized risk counseling and decision support through a web-based tool may be an effective way to allow women to make informed, values-consistent risk management decisions without increasing distress. METHODS/ DESIGN: This paper describes the design and methods of Engaged, a prospective, randomized controlled trial examining the effect of online personalized risk counseling and decision support on risk management decisions in women with dense breasts and increased breast cancer risk. The trial is embedded in a large integrated health care system in the Pacific Northwest. A total of 1250 female health plan members aged 40-69 with a recent negative screening mammogram who are at increased risk for interval cancer based on their 5-year breast cancer risk and BI-RADS® breast density will be randomly assigned to access either a personalized web-based counseling and decision support tool or standard educational content. Primary outcomes will be assessed using electronic health record data (i.e., chemoprevention and breast MRI utilization) and telephone surveys (i.e., distress) at baseline, six weeks, and twelve months. DISCUSSION: Engaged will provide evidence about whether a web-based personalized risk counseling and decision support tool is an effective method for communicating with women about breast density and risk management. An effective intervention could be disseminated with minimal clinical burden to align with density disclosure mandates. Clinical Trials Registration Number:NCT03029286.
RCT Entities:
BACKGROUND: Mammographic breast density is one of the strongest risk factors for breast cancer after age and family history. Mandatory breast density disclosure policies are increasing nationally without clear guidance on how to communicate density status to women. Coupling density disclosure with personalized risk counseling and decision support through a web-based tool may be an effective way to allow women to make informed, values-consistent risk management decisions without increasing distress. METHODS/ DESIGN: This paper describes the design and methods of Engaged, a prospective, randomized controlled trial examining the effect of online personalized risk counseling and decision support on risk management decisions in women with dense breasts and increased breast cancer risk. The trial is embedded in a large integrated health care system in the Pacific Northwest. A total of 1250 female health plan members aged 40-69 with a recent negative screening mammogram who are at increased risk for interval cancer based on their 5-year breast cancer risk and BI-RADS® breast density will be randomly assigned to access either a personalized web-based counseling and decision support tool or standard educational content. Primary outcomes will be assessed using electronic health record data (i.e., chemoprevention and breast MRI utilization) and telephone surveys (i.e., distress) at baseline, six weeks, and twelve months. DISCUSSION: Engaged will provide evidence about whether a web-based personalized risk counseling and decision support tool is an effective method for communicating with women about breast density and risk management. An effective intervention could be disseminated with minimal clinical burden to align with density disclosure mandates. Clinical Trials Registration Number:NCT03029286.
Authors: Suzanne C O'Neill; Tiffani DeMarco; Beth N Peshkin; Sarah Rogers; Jessica Rispoli; Karen Brown; Heiddis Valdimarsdottir; Marc D Schwartz Journal: Am J Med Genet C Semin Med Genet Date: 2006-11-15 Impact factor: 3.908
Authors: Brian L Sprague; Ronald E Gangnon; Veronica Burt; Amy Trentham-Dietz; John M Hampton; Robert D Wellman; Karla Kerlikowske; Diana L Miglioretti Journal: J Natl Cancer Inst Date: 2014-09-12 Impact factor: 13.506
Authors: Karen J Wernli; Wendy B DeMartini; Laura Ichikawa; Constance D Lehman; Tracy Onega; Karla Kerlikowske; Louise M Henderson; Berta M Geller; Mike Hofmann; Bonnie C Yankaskas Journal: JAMA Intern Med Date: 2014-01 Impact factor: 21.873
Authors: Aubri S Hoffman; Robert J Volk; Anton Saarimaki; Christine Stirling; Linda C Li; Martin Härter; Geetanjali R Kamath; Hilary Llewellyn-Thomas Journal: BMC Med Inform Decis Mak Date: 2013-11-29 Impact factor: 2.796
Authors: Jennifer S Haas; Catherine S Giess; Kimberly A Harris; Julia Ansolabehere; Celia P Kaplan Journal: J Gen Intern Med Date: 2018-08-08 Impact factor: 5.128
Authors: Janet Jull; Sascha Köpke; Maureen Smith; Meg Carley; Jeanette Finderup; Anne C Rahn; Laura Boland; Sandra Dunn; Andrew A Dwyer; Jürgen Kasper; Simone Maria Kienlin; France Légaré; Krystina B Lewis; Anne Lyddiatt; Claudia Rutherford; Junqiang Zhao; Tamara Rader; Ian D Graham; Dawn Stacey Journal: Cochrane Database Syst Rev Date: 2021-11-08
Authors: Claire C Conley; Karen J Wernli; Sarah Knerr; Tengfei Li; Kathleen Leppig; Kelly Ehrlich; David Farrell; Hongyuan Gao; Erin J A Bowles; Amanda L Graham; George Luta; Jinani Jayasekera; Jeanne S Mandelblatt; Marc D Schwartz; Suzanne C O'Neill Journal: J Cancer Educ Date: 2021-11-23 Impact factor: 1.771
Authors: Siobhan S Mahorter; Sarah Knerr; Erin J Aiello Bowles; Karen J Wernli; Hongyuan Gao; Marc D Schwartz; Suzanne C O'Neill Journal: Cancer Date: 2020-01-24 Impact factor: 6.860
Authors: Karen J Wernli; Erin A Bowles; Sarah Knerr; Kathleen A Leppig; Kelly Ehrlich; Hongyuan Gao; Marc D Schwartz; Suzanne C O'Neill Journal: Perm J Date: 2020-12
Authors: Erin J Aiello Bowles; Suzanne C O'Neill; Tengfei Li; Sarah Knerr; Jeanne S Mandelblatt; Marc D Schwartz; Jinani Jayasekera; Kathleen Leppig; Kelly Ehrlich; David Farrell; Hongyuan Gao; Amanda L Graham; George Luta; Karen J Wernli Journal: J Womens Health (Larchmt) Date: 2021-09-28 Impact factor: 2.681
Authors: Karen J Wernli; Sarah Knerr; Tengfei Li; Kathleen Leppig; Kelly Ehrlich; David Farrell; Hongyuan Gao; Erin J A Bowles; Amanda L Graham; George Luta; Jinani Jayasekera; Jeanne S Mandelblatt; Marc D Schwartz; Suzanne C O'Neill Journal: JNCI Cancer Spectr Date: 2021-01-14